Hardean Achneck, MD resigned from his position as Executive Vice President, Chief Medical Officer.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics management to meet virtually with Piper Sandler
- Aligos’ New Phase 1 Hepatitis B Study Signals Steady Progress in High-Need Market
- Aligos Therapeutics appoints James Hassard as EVP, CCO
- Aligos Therapeutics initiated with a Buy at UBS
- Aligos Therapeutics announces inducement grants under Nasdaq listing rule